{"id":"https://openalex.org/W619254533","doi":null,"title":"Protein adducts from the anti-HIV drug abacavir \u2013 possible biomarkers of drug toxicity","display_name":"Protein adducts from the anti-HIV drug abacavir \u2013 possible biomarkers of drug toxicity","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W619254533","mag":"619254533"},"language":"en","primary_location":{"id":"pmh:oai:run.unl.pt:10362/8203","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10362/8203","pdf_url":"https://run.unl.pt/bitstreams/7d213d74-9b75-462c-8a90-8b248d62d624/download","source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"master thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://run.unl.pt/bitstreams/7d213d74-9b75-462c-8a90-8b248d62d624/download","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056743513","display_name":"N\u00e1dia M. Grilo","orcid":"https://orcid.org/0000-0001-8936-0675","observed_orcids":["https://orcid.org/0000-0001-8936-0675"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"N\u00e1dia Filipa Marques Grilo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5056743513"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.6050000190734863,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.6050000190734863,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.2639000117778778,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.03840000182390213,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abacavir","display_name":"abacavir","score":1.0},{"id":"https://openalex.org/keywords/protein-adducts","display_name":"protein adducts","score":0.8920000195503235},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.843999981880188},{"id":"https://openalex.org/keywords/nucleoside-reverse-transcriptase-inhibitors","display_name":"nucleoside reverse transcriptase inhibitors","score":0.8460000157356262},{"id":"https://openalex.org/keywords/metabolic-activation","display_name":"metabolic activation","score":0.6439999938011169},{"id":"https://openalex.org/keywords/hemoglobin-adducts","display_name":"hemoglobin adducts","score":0.8759999871253967},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.6340000033378601},{"id":"https://openalex.org/keywords/antiretroviral-therapy-adverse-effects","display_name":"antiretroviral therapy adverse effects","score":0.8320000171661377},{"id":"https://openalex.org/keywords/human-drug-metabolism","display_name":"human drug metabolism","score":0.47200000286102295}],"concepts":[{"id":"https://openalex.org/C2779465607","wikidata":"https://www.wikidata.org/wiki/Q304330","display_name":"Abacavir","level":5,"score":0.9139226675033569},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.7651703357696533},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5665788054466248},{"id":"https://openalex.org/C3018457394","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral drug","level":5,"score":0.5113003253936768},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4970100224018097},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4896460175514221},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4277811646461487},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.30406227707862854},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.21571388840675354},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18436604738235474},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.08487272262573242}],"mesh":[],"locations_count":2,"locations":[{"id":"pmh:oai:run.unl.pt:10362/8203","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10362/8203","pdf_url":"https://run.unl.pt/bitstreams/7d213d74-9b75-462c-8a90-8b248d62d624/download","source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"master thesis"},{"id":"mag:619254533","doi":null,"is_oa":false,"landing_page_url":"https://run.unl.pt/bitstream/10362/8203/1/Grilo_2012.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":{"id":"pmh:oai:run.unl.pt:10362/8203","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10362/8203","pdf_url":"https://run.unl.pt/bitstreams/7d213d74-9b75-462c-8a90-8b248d62d624/download","source":{"id":"https://openalex.org/S4306402433","display_name":"Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"master thesis"},"sustainable_development_goals":[{"score":0.9789000153541565,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W619254533.pdf","grobid_xml":"https://content.openalex.org/works/W619254533.grobid-xml"},"referenced_works_count":75,"referenced_works":["https://openalex.org/W28488281","https://openalex.org/W52579532","https://openalex.org/W159683066","https://openalex.org/W1532674929","https://openalex.org/W1556814137","https://openalex.org/W1677033108","https://openalex.org/W1891945058","https://openalex.org/W1895014795","https://openalex.org/W1955016433","https://openalex.org/W1971234129","https://openalex.org/W1973403929","https://openalex.org/W1977540483","https://openalex.org/W1982448585","https://openalex.org/W1993860399","https://openalex.org/W1999937801","https://openalex.org/W2001431794","https://openalex.org/W2002263828","https://openalex.org/W2003678292","https://openalex.org/W2008510608","https://openalex.org/W2009584249","https://openalex.org/W2015336046","https://openalex.org/W2016352459","https://openalex.org/W2016842950","https://openalex.org/W2019630785","https://openalex.org/W2019855029","https://openalex.org/W2022980866","https://openalex.org/W2028522906","https://openalex.org/W2030670326","https://openalex.org/W2031845569","https://openalex.org/W2031991206","https://openalex.org/W2032774657","https://openalex.org/W2034727191","https://openalex.org/W2037879088","https://openalex.org/W2040846047","https://openalex.org/W2041426680","https://openalex.org/W2043376237","https://openalex.org/W2053449731","https://openalex.org/W2054143023","https://openalex.org/W2056025226","https://openalex.org/W2056295780","https://openalex.org/W2058138075","https://openalex.org/W2063093761","https://openalex.org/W2063487279","https://openalex.org/W2065487115","https://openalex.org/W2067881651","https://openalex.org/W2069455040","https://openalex.org/W2070933534","https://openalex.org/W2081389182","https://openalex.org/W2087206099","https://openalex.org/W2092736862","https://openalex.org/W2094465161","https://openalex.org/W2099986186","https://openalex.org/W2101761365","https://openalex.org/W2112182958","https://openalex.org/W2118826311","https://openalex.org/W2130470659","https://openalex.org/W2136008225","https://openalex.org/W2137146513","https://openalex.org/W2138336199","https://openalex.org/W2139798209","https://openalex.org/W2140055542","https://openalex.org/W2143910776","https://openalex.org/W2148750104","https://openalex.org/W2151128360","https://openalex.org/W2154543112","https://openalex.org/W2156404814","https://openalex.org/W2161643992","https://openalex.org/W2162705413","https://openalex.org/W2167619244","https://openalex.org/W2167865974","https://openalex.org/W2168850597","https://openalex.org/W2334478510","https://openalex.org/W2399195461","https://openalex.org/W2587150119","https://openalex.org/W2952608443"],"related_works":["https://openalex.org/W2275471954","https://openalex.org/W2046613162","https://openalex.org/W2122013167","https://openalex.org/W2416727760","https://openalex.org/W3173572616","https://openalex.org/W7020847624","https://openalex.org/W3019998786","https://openalex.org/W4239637947","https://openalex.org/W839116343","https://openalex.org/W2014533894"],"abstract_inverted_index":{"While":[0,58],"the":[1,9,16,59,120,127,135,144,161,183,191,212,253,267,271,279,301,307,314,330],"benefits":[2],"of":[3,12,55,114,123,129,163,185,193,203,227,241,256,273,282,309,316,332,334],"combined":[4],"antiretroviral":[5],"therapy":[6],"have":[7],"revolutionized":[8],"life":[10],"expectancy":[11],"patients":[13,209,321],"infected":[14,157,210],"with":[15,33,51,211,247],"human":[17,153,213,262],"immunodeficiency":[18,154,214],"virus,":[19],"treatment-associated":[20],"toxicity":[21],"is":[22,26,77,322,326],"frequently":[23],"observed.":[24],"Abacavir":[25],"a":[27,73,81,89,148,274],"nucleoside":[28],"reverse":[29],"transcriptase":[30],"inhibitor":[31],"associated":[32,50],"acute":[34],"toxic":[35,318],"events,such":[36],"as":[37,49,88],"hypersensitivity":[38,63],"reactions.":[39],"In":[40],"addition,":[41],"its":[42,94],"long-term":[43],"use":[44],"has":[45,96],"increasingly":[46],"been":[47],"recognized":[48],"an":[52,292],"increased":[53],"risk":[54],"myocardial":[56],"infarction.":[57],"mechanisms":[60],"underlying":[61],"abacavirinduced":[62],"and":[64,159,206,261,298,313,325],"cardiotoxicity":[65],"are":[66],"not":[67,290],"fully":[68],"understood,":[69],"abacavir":[70,130,145,283,299],"bioactivation":[71,146],"to":[72,79,147,168,181],"reactive":[74,149,165],"aldehyde":[75,150,276],"metabolite":[76,166],"thought":[78],"play":[80],"crucial":[82],"role":[83,128],"in":[84,132,152,188,198,208,250,259,278,284,320],"this":[85,164,287],"context.":[86],"However,":[87],"short":[90],"lived":[91],"specie,in":[92],"vivo,":[93],"formation":[95,308],"so":[97],"far":[98],"eluded":[99],"detection.":[100],"Our":[101],"initial":[102],"hypothesis":[103],"was":[104,138,196],"that":[105],"it":[106],"could":[107],"be":[108],"efficiently":[109],"trapped":[110],"by":[111,233],"N-terminal":[112],"valine":[113],"hemoglobin,":[115],"forming":[116],"N-terminal-valine-abacavir":[117],"adducts.":[118],"With":[119],"ultimate":[121],"goal":[122],"gain":[124],"insight":[125],"into":[126],"metabolism":[131],"abacavir-induced":[133,317,335],"toxicity,":[134,300],"present":[136],"work":[137],"focused":[139],"on":[140,160,270],"obtaining":[141],"evidence":[142,288],"for":[143,201,224,303],"metabolite,":[151],"virus":[155],"-":[156],"patients,":[158],"evaluation":[162],"ability":[167],"undergo":[169],"protein":[170,311],"modification.":[171],"To":[172],"address":[173],"these":[174,186,257],"issues:":[175],"1)":[176],"abacavir-Edman":[177,194,243,296],"standards":[178,248],"were":[179],"prepared":[180,249],"monitor":[182],"presence":[184,192],"adducts":[187,229,258,297,312],"vivo;":[189],"2)":[190],"adduct":[195],"screened":[197],"Wistar":[199],"rats,":[200],"optimization":[202],"analytical":[204],"method;":[205],"3)":[207],"virus.":[215],"The":[216],"experimental":[217],"approach":[218],"used,":[219],"involving":[220],"N-Alkyl":[221],"Edman":[222],"degradation,":[223],"specific":[225],"detachment":[226],"N-terminal-valineabacavir":[228],"from":[230],"protein,":[231],"followed":[232],"liquid":[234],"chromatography-electrospray":[235],"ionization":[236],"tandem":[237],"mass":[238],"spectrometry":[239],"analysis":[240],"detached":[242],"adducts,":[244],"upon":[245],"comparison":[246],"vitro,":[251],"allowed":[252],"unequivocal":[254],"identification":[255],"animal":[260],"samples.":[263],"These":[264],"results":[265],"represent":[266],"first":[268],"report":[269],"involvement":[272],"conjugated":[275],"intermediate":[277],"metabolic":[280],"activation":[281],"man.":[285],"Whereas":[286],"does":[289],"imply":[291],"exclusive":[293],"relation":[294],"between":[295,306],"search":[302],"causal":[304],"relationships":[305],"abacabir-derived":[310],"occurrence":[315],"events":[319],"worth":[323],"pursuing,":[324],"currently":[327],"underway,":[328],"towards":[329],"clarification":[331],"mechanism(s)":[333],"toxicity.":[336]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2016-06-24T00:00:00"}